Long School of Medicine

UT Health San Antonio to lead $11 million, NIH-funded study of a first-ever oral chlamydia vaccine

<p>The study of a novel oral vaccine that could protect against chlamydia infection has been awarded approximately $11 million in National Institutes of Health funding over five years through a cooperative agreements research project grant, known as a U01 grant. “We are excited about receiving the U01 award because it will enable us to move [&hellip;]</p>

Share This Story